Articles by J. Rosenstock (3)

Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial

R. E. Ratner, J. Rosenstock and G. Boka

Diabetic Medicine 27 ( 9 ): 1024 - 1032 , 2010

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes

J. Rosenstock, A. J. Lewin, P. Norwood, V. Somayaji, T. T. Nguyen, J. G. Teeter, S. L. Johnson, H. Dai and S. G. Terra

Diabetic Medicine 28 ( 4 ): 464 - 469 , 2011

Long-term 4-year safety of saxagliptin in drug-naive and metformin-treated patients with Type 2 diabetes

J. Rosenstock, J. L. Gross, C. Aguilar-Salinas, M. Hissa, N. Berglind, S. Ravichandran and D. Fleming

Diabetic Medicine 30 ( 12 ): 1472 - 1476 , 2013

Do you have a suggestion for journals

Suggest Journal